International Video Corporation

Invacare Corporation to Participate in the 6th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference

Retrieved on: 
Monday, August 2, 2021
Medical devices, Health, Elyria, Ohio, Invacare, IVC, International Video Corporation, New York Stock Exchange, Needham, Massachusetts, Economy of the United States

Matt Monaghan, chairman, president and chief executive officer of Invacare Corporation (NYSE: IVC); Kathy Leneghan, senior vice president and chief financial officer; and Lois Lee, director, treasury, investor relations & corporate communications, will participate in 6th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on Tuesday, August 17, 2021 .

Key Points: 
  • Matt Monaghan, chairman, president and chief executive officer of Invacare Corporation (NYSE: IVC); Kathy Leneghan, senior vice president and chief financial officer; and Lois Lee, director, treasury, investor relations & corporate communications, will participate in 6th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on Tuesday, August 17, 2021 .
  • The companys management team will be available for 1x1 meetings with interested investors.
  • Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings.
  • At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene.

Invacare Corporation to Host Conference Call and Webcast to Discuss Second Quarter 2021 Financial Results

Retrieved on: 
Monday, July 26, 2021
Medical devices, Health, Elyria, Ohio, Invacare, IVC, New York Stock Exchange, International Video Corporation, Economy of the United States

Invacare Corporation (NYSE: IVC) (Invacare or the company) announces that it will release its financial results for the second quarter 2021, after the market closes on Wednesday, August 4, 2021.

Key Points: 
  • Invacare Corporation (NYSE: IVC) (Invacare or the company) announces that it will release its financial results for the second quarter 2021, after the market closes on Wednesday, August 4, 2021.
  • The company will provide a live conference call and webcast to discuss these financial results on Thursday, August 5, 2021 at 8:30 AM ET.
  • A copy of the webcast slide deck will be posted to www.invacare.com/investorrelations prior to the webcast.
  • Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings.

Invacare Corporation to Participate in the 21st Annual CJS Securities New Ideas Summer Conference

Retrieved on: 
Monday, June 28, 2021
Health, General Health, Elyria, Ohio, Invacare, IVC, International Video Corporation, New York Stock Exchange, Economy of the United States

Matt Monaghan, chairman, president and chief executive officer of Invacare Corporation (NYSE: IVC); Kathy Leneghan, senior vice president and chief financial officer; and Lois Lee, director, treasury, investor relations and corporate communications, will participate in the 21st Annual New Ideas Summer Conference on Tuesday, July 13, 2021.

Key Points: 
  • Matt Monaghan, chairman, president and chief executive officer of Invacare Corporation (NYSE: IVC); Kathy Leneghan, senior vice president and chief financial officer; and Lois Lee, director, treasury, investor relations and corporate communications, will participate in the 21st Annual New Ideas Summer Conference on Tuesday, July 13, 2021.
  • The companys management team will be available for 1x1 meetings with interested investors.
  • Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings.
  • At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene.

INVO Bioscience Appoints Andrea Goren as Chief Financial Officer

Retrieved on: 
Tuesday, June 15, 2021
Goren, International Video Corporation

SARASOTA, Fla., June 15, 2021 /PRNewswire/ --INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcell, an effective and affordable treatment for patients diagnosed with infertility, today announced the appointment of Andrea Goren as the Company's chief financial officer.

Key Points: 
  • SARASOTA, Fla., June 15, 2021 /PRNewswire/ --INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcell, an effective and affordable treatment for patients diagnosed with infertility, today announced the appointment of Andrea Goren as the Company's chief financial officer.
  • Steve Shum, CEO of INVO Bioscience, said, "We are pleased to appoint a financial executive the caliber of Andrea Goren as chief financial officer of INVO Bioscience.
  • Andrea has been serving INVO over the past year in a consulting capacity and thus is familiar with the operations of the company, including many within the finance function.
  • Andrea Goren commented, "I am pleased to be joining INVO Bioscience in a full-time capacity as the chief financial officer.

Invacare Corporation to Present at the UBS Global Healthcare Virtual Conference

Retrieved on: 
Wednesday, May 12, 2021
Medical devices, Health, Elyria, Ohio, Invacare, International Video Corporation

b"Invacare Corporation (NYSE:IVC) (the \xe2\x80\x9cCompany\xe2\x80\x9d), a leading manufacturer and distributor of medical equipment used in non-acute care settings, announced that Matt Monaghan, chairman, president and chief executive officer will present at the UBS Global Healthcare Virtual Conference on Tuesday, May 25, 2021 at 4:00 p.m.

Key Points: 
  • b"Invacare Corporation (NYSE:IVC) (the \xe2\x80\x9cCompany\xe2\x80\x9d), a leading manufacturer and distributor of medical equipment used in non-acute care settings, announced that Matt Monaghan, chairman, president and chief executive officer will present at the UBS Global Healthcare Virtual Conference on Tuesday, May 25, 2021 at 4:00 p.m.
  • At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene.
  • The company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia/Pacific.
  • For more information about the company and its products, visit Invacare's website at www.invacare.com .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210512005960/en/\n"

Invacare Corporation to Host Conference Call and Webcast to Discuss First Quarter 2021 Financial Results

Retrieved on: 
Friday, April 23, 2021
Other Consumer, Medical devices, Seniors, Hospitals, Other Health, Managed care, Health, Consumer, General Health, Elyria, Ohio, Invacare, International Video Corporation

b"Invacare Corporation (NYSE: IVC) (\xe2\x80\x9cInvacare\xe2\x80\x9d or the \xe2\x80\x9ccompany\xe2\x80\x9d) announces that it will release its financial results for the first quarter 2021, after the market closes on Wednesday, May 5, 2021.

Key Points: 
  • b"Invacare Corporation (NYSE: IVC) (\xe2\x80\x9cInvacare\xe2\x80\x9d or the \xe2\x80\x9ccompany\xe2\x80\x9d) announces that it will release its financial results for the first quarter 2021, after the market closes on Wednesday, May 5, 2021.
  • At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene.
  • The company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia/Pacific.
  • For more information about the company and its products, visit Invacare's website at www.invacare.com .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210423005334/en/\n"

Invacare Corporation to Present at the 20th Annual Needham Virtual Healthcare Conference

Retrieved on: 
Tuesday, March 30, 2021
General Health, Health, Medical devices, Elyria, Ohio, Invacare, International Video Corporation, IVC, Needham, Massachusetts, Acute care, Economy of the United States, States of the United States

Invacare Corporation (NYSE:IVC)(the Company), a leading manufacturer and distributor of medical equipment used in non-acute care settings, announced that Matt Monaghan, chairman, president and chief executive officer will participate in a fireside chat at the 20th Annual Needham Virtual Healthcare Conference on Monday, April 12, 2021 at 2:15 p.m.

Key Points: 
  • Invacare Corporation (NYSE:IVC)(the Company), a leading manufacturer and distributor of medical equipment used in non-acute care settings, announced that Matt Monaghan, chairman, president and chief executive officer will participate in a fireside chat at the 20th Annual Needham Virtual Healthcare Conference on Monday, April 12, 2021 at 2:15 p.m.
  • The live webcast of the presentation will be available at https://wsw.com/webcast/needham107/ivc/2061268 and it will be accessible for replay for 90 days following the conference.
  • Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings.
  • At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene.

INVO Bioscience to Present at the Lytham Partners Spring 2021 Investor Conference

Retrieved on: 
Monday, March 29, 2021
Fertility medicine, Women's health, Infertility, Mycoplasma, Intravaginal administration, International Video Corporation

SARASOTA, Fla., March 29, 2021 /PRNewswire/ --INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcell, an effective and affordable treatment for patients diagnosed with infertility, announced today that it will present at the Lytham Partners Spring 2021 Investor Conference on Thursday, April 1, 2021 at 4:15pm ET.

Key Points: 
  • SARASOTA, Fla., March 29, 2021 /PRNewswire/ --INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcell, an effective and affordable treatment for patients diagnosed with infertility, announced today that it will present at the Lytham Partners Spring 2021 Investor Conference on Thursday, April 1, 2021 at 4:15pm ET.
  • Management will also be participating in virtual one-on-one meetings throughout the event, which runs from March 30, 2021 through April 1, 2021.
  • To arrange a meeting, please contact Lytham Partners at [email protected] or register at www.lythampartners.com/spring2021reg .
  • Our solution, the INVO Procedure, is a revolutionary in vivo method of vaginal incubation that offers patients a more natural and intimate experience.

INVO Bioscience to Participate in the 33rd Annual Roth Conference

Retrieved on: 
Thursday, March 11, 2021
Fertility medicine, Women's health, Infertility, Mycoplasma, Intravaginal administration, International Video Corporation

SARASOTA, Fla., March 11, 2021 /PRNewswire/ --INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcell, an effective and affordable treatment for patients diagnosed with infertility, today announced it will participate in the 33rd Annual ROTH Conference, which will be held virtually from March 15-17, 2021.

Key Points: 
  • SARASOTA, Fla., March 11, 2021 /PRNewswire/ --INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcell, an effective and affordable treatment for patients diagnosed with infertility, today announced it will participate in the 33rd Annual ROTH Conference, which will be held virtually from March 15-17, 2021.
  • INVO Bioscience management will participate in one-on-one meetings with investors and analysts during the conference.
  • To schedule a one-on-one meeting, please contact your ROTH representative.
  • Our solution, the INVO Procedure, is a revolutionary in vivo method of vaginal incubation that offers patients a more natural and intimate experience.

Invacare Corporation Proposed Offering of $100 Million Aggregate Principal Amount of Convertible Senior Notes

Retrieved on: 
Wednesday, March 10, 2021
General Health, Medical devices, Other Health, Health, Managed care, Financial market, Convertible security, International Video Corporation

Upon conversion, the notes may be settled in cash, the Companys common shares or a combination of cash and the Companys common shares, at the Companys election.

Key Points: 
  • Upon conversion, the notes may be settled in cash, the Companys common shares or a combination of cash and the Companys common shares, at the Companys election.
  • The Company may use any remaining net proceeds of the offering for working capital and general corporate purposes, which may include repurchases of the Companys other outstanding convertible senior notes.
  • Invacare Corporation (NYSE: IVC) is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings.
  • Other risks to potential purchasers of the notes include those described in the applicable private offering memorandum.